Literature DB >> 18097651

Effects of rosiglitazone on altered electrical left ventricular papillary muscle activities of diabetic rat.

Servet Kavak1, Mustafa Emre, Tamer Tetiker, Tuyana Kavak, Zekeriya Kolcu, Ismail Günay.   

Abstract

The action potential configuration of the left ventricular papillary muscle as well as the rosiglitazone-dependent changes in ventricular papillary muscle action potential amplitude were studied, and the duration was studied and compared in both healthy and diabetic rats. In this study, we used four groups: (1) nondiabetic control animals (C), (2) rosiglitazone-treated nondiabetic control animals (C+RSG), (3) diabetic animals (D), and (4) rosiglitazone-treated diabetic animals (D+RSG). Diabetes was induced by a single intravenous (i.v.) injection of streptozotocin (STZ). Conventional microelectrode techniques were applied to record action potentials after the establishment of diabetes (8 weeks after STZ treatment). Resting membrane potential (RMP) was decreased significantly in both RSG-treated C and D rats (from -70.2 +/- 0.7 to -63.2 +/- 0.7 and from -69.2 +/- 0.4 to -61.2 +/- 0.4). C+RSG and D+RSG groups showed increase in action potential amplitude compared with C and D groups (from 67.1 +/- 0.8 to 68.2 +/- 0.5 and from 67.1 +/- 0.8 to 80.1 +/- 0.8 and from 68.2 +/- 0.5 to 79.3 +/- 0.3) Depolarization time was significantly prolonged in diabetic rats (12.1 +/- 0.4 to 27.5 +/- 0.9). However, this prolongation in D+RSG group was significantly lower according to D group (from 27.5 +/- 0.9 to 19.2 +/- 0.7). There was no difference between C and C+RSG rats (12.1 +/- 0.4 to 11.6 +/- 0.2). Half repolarization time was also prolonged in diabetic rats (17.5 +/- 0.6 to 59.9 +/- 1.0). Moreover, D+RSG rats showed a slight and statistically insignificant difference according D rats (59.9 +/- 1.0 to 55.9 +/- 1.7). C+RSG rats showed a slight significant increase in half repolarization time compared with C group (17.5 +/- 0.6 to 29.4 +/- 0.7). Treatment of rats with RSG markedly decreased insulin resistance and also increased insulin sensitivity of the heart. Our data suggest that the beneficial effects of RSG treatment on the electrical activities of the diabetic rat papillary appear to be due to the diminished K+ currents, partially related to the decrease of hyperglycemia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18097651     DOI: 10.1007/s00210-007-0234-y

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  30 in total

Review 1.  Cardiovascular disease and hypertension in diabetes mellitus.

Authors:  R J Jarrett
Journal:  Diabetes Metab Rev       Date:  1989-11

2.  Comparative actions of insulin sensitizers on ion channels in vascular smooth muscle.

Authors:  K Eto; Y Ohya; Y Nakamura; I Abe; M Fujishima
Journal:  Eur J Pharmacol       Date:  2001-06-29       Impact factor: 4.432

Review 3.  Thiazolidinediones in the treatment of insulin resistance and type II diabetes.

Authors:  A R Saltiel; J M Olefsky
Journal:  Diabetes       Date:  1996-12       Impact factor: 9.461

4.  Differential effects of insulin-sensitizers troglitazone and rosiglitazone on ion currents in rat vascular myocytes.

Authors:  G A Knock; S K Mishra; P I Aaronson
Journal:  Eur J Pharmacol       Date:  1999-02-26       Impact factor: 4.432

5.  Increased susceptibility to hypoxia of prolonged action potential duration in ventricular papillary muscles from diabetic rats.

Authors:  M Aomine; S Nobe; M Arita
Journal:  Diabetes       Date:  1990-12       Impact factor: 9.461

6.  Effect of pioglitazone on vascular reactivity in vivo and in vitro.

Authors:  T A Kotchen; H Y Zhang; S Reddy; R G Hoffmann
Journal:  Am J Physiol       Date:  1996-03

7.  Remifentanil-induced mechanical responses and membrane potential changes in human umbilical arteries.

Authors:  H Unlugenc; M Emre; C Demir; T Guler; S Kavak; G Isik
Journal:  Acta Anaesthesiol Scand       Date:  2006-12-15       Impact factor: 2.105

Review 8.  Diabetes mellitus and cardiac function.

Authors:  M A Mahgoub; A S Abd-Elfattah
Journal:  Mol Cell Biochem       Date:  1998-03       Impact factor: 3.396

Review 9.  Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications.

Authors:  Zhi You Fang; Johannes B Prins; Thomas H Marwick
Journal:  Endocr Rev       Date:  2004-08       Impact factor: 19.871

10.  Altered myocardial mechanics in diabetic rats.

Authors:  F S Fein; L B Kornstein; J E Strobeck; J M Capasso; E H Sonnenblick
Journal:  Circ Res       Date:  1980-12       Impact factor: 17.367

View more
  4 in total

1.  Effects of rosiglitazone on the configuration of action potentials and ion currents in canine ventricular cells.

Authors:  N Szentandrássy; G Harmati; L Bárándi; J Simkó; B Horváth; J Magyar; T Bányász; I Lorincz; A Szebeni; V Kecskeméti; P P Nánási
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

2.  Effects of insulin on altered mechanical and electrical papillary muscle activities of diabetic rats.

Authors:  Servet Kavak
Journal:  J Membr Biol       Date:  2012-09-12       Impact factor: 1.843

3.  Effects of Theophylline with Methylprednisolone Combination Therapy on Biomechanics and Histopathology in Diaphragm Muscles of Rats.

Authors:  Nureddin Yuzkat; Ismail Kati; Yasemin Isik; Servet Kavak; Ugur Goktas; Nurettin Cengiz
Journal:  Inflammation       Date:  2016-10       Impact factor: 4.092

4.  Can the electrophysiological action of rosiglitazone explain its cardiac side effects?

Authors:  A Szebeni; N Szentandrássy; P Pacher; J Simkó; P P Nánási; V Kecskeméti
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.